Gregory Eippert, MD
Ophthalmology · Mentor, OHNPI 1730181934
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $728,238 of the $812,584 with a category attached, or 89.6%. Alcon Research LLC accounts for 88.9% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2023 at $728,615 and has fallen 96.7% since, to $23,838 in 2025. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 365 payments — averaging $2226.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$723K
- Alcon$79K
- Microsurgical Technology, Inc.$6K
- AbbVie$991
- Dutch Ophthalmic, USA$664
- Novartis$461
- plus $3K from 24 others
Across 1 payment — averaging $1445.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$1K
What the payments were for
- Royalty or licence$728,23890%
- Consulting fees$71,7239%
- Travel & lodging$1,6820%
- Food & beverage$10,8121%
- Education$1100%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 1 | $722,646 |
| Alcon | 167 | $79,455 |
| Microsurgical Technology, Inc. | 4 | $5,591 |
| AbbVie(2 entities) | 38 | $991 |
| Dutch Ophthalmic, USA | 6 | $664 |
| Novartis | 29 | $461 |
| Sight Sciences, Inc. | 11 | $389 |
| Ivantis, Inc | 7 | $347 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 19 | $305 |
| Shire North American Group Inc | 9 | $227 |
| Oyster Point Pharma, Inc. | 8 | $182 |
| Sun Pharmaceutical Industries Inc. | 10 | $173 |
| Bausch & Lomb Americas Inc. | 10 | $172 |
| NEW World Medical,inc. | 2 | $135 |
| Biotissue Holdings Inc. | 6 | $119 |
| Aerie Pharmaceuticals, Inc. | 5 | $98 |
| Dompe US, Inc. | 4 | $94 |
| Amgen(2 entities) | 5 | $86 |
| Kala Pharmaceuticals, Inc. | 5 | $70 |
| Carl Zeiss Meditec, Inc. | 1 | $65 |
| Harrow Eye, LLC | 2 | $56 |
| Omeros Corporation | 4 | $50 |
| Glaukos Corporation | 2 | $45 |
| Thea Pharma Inc. | 2 | $39 |
| Tarsus Pharmaceuticals, Inc. | 2 | $36 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $26 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Mallinckrodt Hospital Products Inc. | 1 | $13 |
| Ocular Therapeutix, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$37,150
- ORA$8,345
- LenSx$5,880
- AcrySof$3,289
- Unity$2,420
- ARGOS$856
- EVA, combined machine$592
- TISSUEBLUE$592
- Hydrus$300
- DURYSTA$271
- OMNI(R) SURGICAL SYSTEM (US)$261
- SION SURGICAL INSTRUMENT$147
- Wavelight$123
- Centurion$122
- Ahmed Glaucoma Valve$120
- Kahook Dual Blade$120
- Wavelight Refractive Suite$118
- AcrySof IQ VIVITY$117
- Rocklatan$111
How this compares
$812,584 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 90 | $44,809 |
| RhopressaNetarsudil Mesylate | 82 | $36,487 |
| XiidraLifitegrast | 21 | $21,735 |
| Travoprost | 176 | $15,344 |
| RocklatanNetarsudil Mesylat/Latanoprost | 45 | $15,032 |
| VyzultaLatanoprostene Bunod | 27 | $11,257 |
| Latanoprost | 1,242 | $8,941 |
| Prednisolone Acetate | 306 | $8,209 |
| CombiganBrimonidine Tartrate/Timolol | 31 | $8,062 |
| Brimonidine Tartrate | 559 | $7,842 |
| Loteprednol Etabonate | 63 | $7,570 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 56 | $6,804 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 393 | $5,800 |
| Dorzolamide Hcl | 340 | $4,761 |
| Alphagan PBrimonidine Tartrate | 15 | $4,235 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Alphagan P | $991 | $57,106136 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $98 | $51,519127 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $172 | $32,99148 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $305 | $7,57063 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 640 ophthalmology providers in Ohio.
Other ophthalmology in Mentor
- Peter KaiserCleveland$1.5M
- Robert OsherCincinnati$720K
- Justis EhlersCleveland$639K
- Lawrence SingermanBeachwood$599K
- Darrell WhiteWestlake$587K
- Alice EpitropoulosColumbus$531K
- Amy MillerDayton$526K
- Sunil SrivastavaCleveland$508K
- William WileyCleveland$479K
- Christopher RiemannCincinnati$463K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.